Blood-brain barrier-specific properties of a human adult brain endothelial cell line

被引:1041
作者
Weksler, BB
Subileau, EA
Perrière, N
Charneau, P
Holloway, K
Leveque, M
Tricoire-Leignel, H
Nicotra, A
Bourdoulous, S
Turowski, P
Male, DK
Roux, F
Greenwood, J
Romero, IA
Couraud, PO
机构
[1] Univ Paris 05, INSERM, Inst Cochin, CNRS,UMR 8104, Paris, France
[2] Open Univ, Dept Biol Sci, Milton Keynes, Bucks, England
[3] Hop Fernand Widal, INSERM, Paris, France
[4] UCL, Inst Ophthalmol, Div Cellular Therapy, London, England
[5] Inst Pasteur, Paris, France
基金
英国惠康基金;
关键词
drug permeability; cellular junctions; multidrug resistance; in vitro model;
D O I
10.1096/fj.04-3458fje
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Establishment of a human model of the blood-brain barrier has proven to be a difficult goal. To accomplish this, normal human brain endothelial cells were transduced by lentiviral vectors incorporating human telomerase or SV40 T antigen. Among the many stable immortalized clones obtained by sequential limiting dilution cloning of the transduced cells, one was selected for expression of normal endothelial markers, including CD31, VE cadherin, and von Willebrand factor. This cell line, termed hCMEC/D3, showed a stable normal karyotype, maintained contact-inhibited monolayers in tissue culture, exhibited robust proliferation in response to endothelial growth factors, and formed capillary tubes in matrix but no colonies in soft agar. hCMEC/D3 cells expressed telomerase and grew indefinitely without phenotypic dedifferentiation. These cells expressed chemokine receptors, up-regulated adhesion molecules in response to inflammatory cytokines, and demonstrated blood-brain barrier characteristics, including tight junctional proteins and the capacity to actively exclude drugs. hCMEC/D3 are excellent candidates for studies of blood-brain barrier function, the responses of brain endothelium to inflammatory and infectious stimuli, and the interaction of brain endothelium with lymphocytes or tumor cells. Thus, hCMEC/D3 represents the first stable, fully characterized, well-differentiated human brain endothelial cell line and should serve as a widely usable research tool.
引用
收藏
页码:1872 / +
页数:26
相关论文
共 52 条
[1]  
Abbott NJ, 1995, NEW CONCEPTS OF A BLOOD-BRAIN BARRIER, P239
[2]  
ABBOTT NJ, 1992, J CELL SCI, V103, P23
[3]  
Allen JD, 2002, MOL CANCER THER, V1, P417
[4]   Characterization of binding sites for chemokines MCP-1 and MIP-1α on human brain microvessels [J].
Andjelkovic, AV ;
Pachter, JS .
JOURNAL OF NEUROCHEMISTRY, 2000, 75 (05) :1898-1906
[5]   ABC transporters and the blood-brain barrier [J].
Begley, DJ .
CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (12) :1295-1312
[6]   Contribution of glial cells and pericytes to the mRNA profiles of P-glycoprotein and multidrug resistance-associated proteins in an in vitro model of the blood-brain barrier [J].
Berezowski, V ;
Landry, C ;
Dehouck, MP ;
Cecchelli, R ;
Fenart, L .
BRAIN RESEARCH, 2004, 1018 (01) :1-9
[7]   CXC and CC chemokine receptors on coronary and brain endothelia [J].
Berger, O ;
Gan, XH ;
Gujuluva, C ;
Burns, AR ;
Sulur, G ;
Stins, M ;
Way, D ;
Witte, M ;
Weinand, M ;
Said, J ;
Kim, KS ;
Taub, D ;
Graves, MC ;
Fiala, M .
MOLECULAR MEDICINE, 1999, 5 (12) :795-805
[8]   Distribution of immunoglobulin superfamily members ICAM-1, -2, -3, and the beta 2 integrin LFA-1 in multiple sclerosis lesions [J].
Bo, L ;
Peterson, JW ;
Mork, S ;
Hoffman, PA ;
Gallatin, WM ;
Ransohoff, RM ;
Trapp, BD .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1996, 55 (10) :1060-1072
[9]   CXCR3 marks CD4+ memory T lymphocytes that are competent to migrate across a human brain microvascular endothelial cell layer [J].
Callahan, MK ;
Williams, KA ;
Kivisäk, P ;
Pearce, D ;
Stins, MF ;
Ransohoff, RM .
JOURNAL OF NEUROIMMUNOLOGY, 2004, 153 (1-2) :150-157
[10]   In vitro model for evaluating drug transport across the blood-brain barrier [J].
Cecchelli, R ;
Dehouck, B ;
Descamps, L ;
Fenart, L ;
Buée-Scherrer, V ;
Duhem, C ;
Lundquist, S ;
Rentfel, M ;
Torpier, G ;
Dehouck, MP .
ADVANCED DRUG DELIVERY REVIEWS, 1999, 36 (2-3) :165-178